SYY
49
9
D
40
2
HRB
59
2
KSS
39
-7
COP
57
-2
KIM
72
2
DE
42
3
REGN
38
-2
LB
30
4
HPE
44
-2
SYF
86
-6
AXP
67
-2
ADP
65
-3
CPB
22
-5
CNP
54
10
AZO
50
-5
HIG
66
2
CNX
73
-3
URI
60
-6
STI
45
26
SYY
49
9
D
40
2
HRB
59
2
KSS
39
-7
COP
57
-2
KIM
72
2
DE
42
3
REGN
38
-2
LB
30
4
HPE
44
-2
SYF
86
-6
AXP
67
-2
ADP
65
-3
CPB
22
-5
CNP
54
10
AZO
50
-5
HIG
66
2
CNX
73
-3
URI
60
-6
STI
45
26
Financhill
Back

Ascendis Pharma AS Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

ASND
Ascendis Pharma AS

Last Price:
123.16
Seasonality Move:
15.69%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.80
Seasonality Move:
17.03%
Sell
30
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $126.51. The Score for ASND is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $126.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.82 Sell
Relative Strength Index (14 RSI): 46.41 Sell
Chaikin Money Flow: 179930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (125.18 - 129.56) Sell
Bollinger Bands (100): (125.03 - 141.75) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.68 Sell
20-day SMA: 126.98 Sell
50-day SMA: 132.15 Sell
200-day SMA: 137.19 Sell
8-day EMA: 126.34 Buy
20-day EMA: 127.69 Sell
50-day EMA: 130.63 Sell
200-day EMA: 130.52 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.91 per share, and an increase next year of $3.95 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):